News from oncolytics biotech inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 19, 2016, 17:14 ET

Oncolytics Biotech® Inc. Announces First Patients Treated in Phase 1b Study in Advanced Pancreatic Cancer

CALGARY, Jan. 19, 2016 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, OTCQX:ONCYF) today announced that the first patients...

Jan 19, 2016, 06:30 ET

Oncolytics Biotech® Inc. Announces First Patients Treated in Phase 1b Study in Advanced Pancreatic Cancer

CALGARY, Jan. 19, 2016 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that the first patients have...

Dec 08, 2015, 06:30 ET

Oncolytics Biotech® Inc. Collaborators Present Multiple Myeloma Data at 57th American Society of Hematology Annual Meeting

-- Emerging Data Support Conducting Additional, Later Stage Studies in Multiple Myeloma -- CALGARY, Dec. 8, 2015 /PRNewswire/ - Oncolytics...

Dec 02, 2015, 06:30 ET

MEDIA ADVISORY - Oncolytics Biotech® Inc. to Present at LD Micro Growth Conference

CALGARY, Dec. 2, 2015 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, OTCQX: ONCYF), will participate in...

Nov 18, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Start of Enrollment in Phase 1b Study of Multiple Myeloma Looking at REOLYSIN® in Combination with Bortezomib

CALGARY, Nov. 18, 2015 /CNW/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, OTCQX:ONCYF) today announced that enrollment has commenced in a...

Nov 05, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces 2015 Third Quarter Results

CALGARY, Nov. 5, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. (TSX:ONC, OTCQX:ONCY) ("Oncolytics" or the "Company") today announced its...

Oct 29, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Receipt of Qualification for Trading on the OTCQX and Nasdaq Notice of Delisting

CALGARY, Oct. 29, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ:ONCY) announced today that it...

Oct 20, 2015, 06:45 ET

Media Advisory - Oncolytics Biotech® Inc. to Participate in the 14th Annual BIO Investor Forum

CALGARY, Oct. 20, 2015 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will...

Oct 20, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Phase 1b Study in Advanced Pancreatic Cancer

-- First Clinical Trial Examining Effects of REOLYSIN® in Combination with a Checkpoint Inhibitor -- CALGARY, Oct. 20, 2015 /PRNewswire/...

Oct 06, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Prostate Cancer Study

CALGARY, Oct. 6, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that enrollment has...

Sep 25, 2015, 06:30 ET

Oncolytics Biotech® Inc. Collaborators Present Data from Clinical Study in Multiple Myeloma

-- All Evaluable Patients to Date See Evidence of an Objective Response; Treatment Combination Associated with Statistically Significant...

Sep 09, 2015, 06:30 ET

Media Advisory - Oncolytics Biotech® Inc. to Participate in the Baird 2015 Healthcare Conference

CALGARY, Sept. 9, 2015 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will participate in...

Aug 27, 2015, 06:30 ET

Oncolytics Biotech® Inc. Collaborators to Present Survival Data from REO 016 Study in Non-Small Cell Lung Cancer

--Report Near Tripling of Two-Year Survival Compared to Historical Controls-- CALGARY, Aug. 27, 2015 /PRNewswire/ - Oncolytics Biotech®...

Aug 26, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Non-Small Cell Lung Cancer Study

CALGARY, Aug. 26, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that enrollment...

Aug 12, 2015, 06:30 ET

MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 35th Annual Canaccord Genuity Growth Conference

CALGARY, Aug. 12, 2015 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will...

Aug 06, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces 2015 Second Quarter Results

CALGARY, Aug. 6, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced its...

Jul 06, 2015, 06:30 ET

Oncolytics Biotech® Inc. Collaborators Present Final Data from REO 017 Clinical Study in Pancreatic Cancer

--Report More Than Doubling in One-Year Survival and Nearly Five-Fold Increase in Two-Year Survival as Compared to Historical...

Jun 15, 2015, 06:30 ET

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 9th International Conference on Oncolytic Virus Therapeutics

CALGARY, June 15, 2015 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that a series of oral and...

Jun 12, 2015, 17:00 ET

Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders

CALGARY, June 12, 2015 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) today announced the voting results from its Annual Meeting...

Jun 09, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Director Election Results from its Annual Meeting of Shareholders

CALGARY, June 9, 2015 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that all nominees listed in the management...